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Background 
Obesity complicates pregnancy with 
increasing frequency and is associated 
with increased antenatal complications 
including preeclampsia and gestational 
diabetes.   A key question remains why 
some pregnancies complicated by 
obesity are associated with poor 
perinatal outcomes while others remain 
largely unaffected.  Adipose tissue 
containing adipocytes and inflammatory 
cells contribute to systemic 
inflammation, hypertension and diabetes 
outside of pregnancy. Chemokine C-C 
motif ligand 2 (CCL-2), which can be 
produced by adipocytes and 
macrophages to augment inflammation 
in multiple organ systems, and Leptin, a 
small molecule produced by adipocytes 
involved in metabolism  and 
inflammation, may contribute to poor 
pregnancy outcomes before symptoms 
are clinically noted. 
Objective 
The objective of this study is to measure 
plasma CCl2 and leptin early in control 
and obese women and associate 
pregnancy outcomes with these levels.  
We hypothesize that early elevations of 
plasma CCL2 will be predictive of the 
development of poor pregnancy 
outcomes. 
 
Study Design 
This is a case control study using 
banked maternal plasma samples at 
less than 20 weeks gestation and 
clinical data obtained from the University 
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of Iowa Tissue bank.  Two cohorts are 
identified including those with a BMI<30 
and those with a BMI>35.   CCl2 and 
Leptin levels are determined by ELISA 
and normalized to total plasma protein. 
Results 
Obese patients with a BMI>35 had a 
statistically significant elevation in CCL2 
to protein ratio compared to those with a 
BMI of less than 30 (0.341 compared to 
0.230 respectively  (P<0.001)).  
Controlling for obesity, elevated levels of 
CCL2:protein were significantly 
associated with development of 
preeclampsia, not gestational diabetes 
or Cesarean delivery.  CCL2:protein 
ratio is moderately predictive of the 
development of preeclampsia (ROC 
AUC=0.70)   While the leptin to protein 
ratio was significantly elevated in those 
with a BMI>35 compared to those with a 
BMI<30.   It was not associated with 
preeclampsia, gestational diabetes and 
C section after controlling for obesity.  
Conclusions 
Elevated levels of CCL2 early in 
pregnancy is associated with 
development of preeclampsia in the 
obese, suggesting that changes in 
obesity associated inflammation, not 
simply the presence of adipose tissue 
contributes to development of 
preeclampsia.   
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